3 of the best Australian stocks to buy after the market selloff

Analysts think these shares could rise strongly from where they trade today.

Key points
  • CSL's shares have dropped due to margin recovery concerns and restructuring costs, but long-term prospects remain robust thanks to a strong plasma business and promising pipeline. Macquarie’s price target suggests significant upside potential, making it an attractive buy for long-term investors.
  • NextDC has been swept down in the tech sector's downturn despite strong market positioning in data storage and cloud services. With Macquarie's bullish price target, its expansion into AI and cloud megatrends offers substantial upside over the year.
  • TechnologyOne's recent share price dip comes despite record earnings and ARR, primarily driven by valuation adjustments rather than business issues. Shaw and Partners recommend buying the dip, projecting nearly 30% upside as the company continues to expand its SaaS+ model and strengthen its R&D capabilities.

The market has taken a beating this month as volatility surged, interest rate uncertainty spooked investors, and tech valuations came under pressure. While that kind of pullback can feel unsettling, it often creates some of the best opportunities long-term investors will see all year.

Several high-quality Australian stocks have been dragged down with the broader market. And for patient investors, that combination of temporary weakness can be a gift.

With that in mind, here are three outstanding Australian stocks that analysts think look compelling after the recent selloff.

A woman wearing dark clothing and sporting a few tattoos and piercings holds a phone and a takeaway coffee cup as she strolls under the Sydney Harbour Bridge which looms in the background.

Image source: Getty Images

CSL Ltd (ASX: CSL)

CSL was for a long time one of the most reliable long-term compounders on the Australian share market. However, its shares have been hit hard over the past year due to concerns around margin recovery, restructuring costs, and uncertainty surrounding the planned Seqirus demerger.

But zoom out, and the long-term investment case remains extremely strong. CSL's core plasma business is benefiting from growing collections, improving efficiencies, and rising global demand for critical therapies. The biotech company continues to invest heavily in its pipeline, with new treatments and market expansions expected to support earnings over the decade ahead.

Importantly, CSL's valuation has become materially more attractive. For example, Macquarie Group Ltd (ASX: MQG) currently has an outperform rating and $275.20 price target on its shares. This implies potential upside of more than 50% from current levels.

NextDC Ltd (ASX: NXT)

Another Australian stock that has fallen heavily from its highs is NextDC.

It has been caught up in the tech-led market pullback, despite its exceptional underlying momentum. The company continues to expand aggressively to meet soaring demand for data storage, cloud services, and high-performance computing. These are structural trends that remain in their early innings.

With hyperscale customers scaling up AI workloads and enterprises shifting more operations into the cloud, NextDC is positioned squarely at the centre of one of the most powerful megatrends of the next decade. Its pipeline of new facilities, long-term contracted revenue, and high customer stickiness give the business a remarkable degree of predictability.

Macquarie also recently put an outperform rating on this stock with a $20.90 price target. This suggests that upside of over 50% is possible over the next 12 months.

TechnologyOne Ltd (ASX: TNE)

Finally, TechnologyOne's share price crash this week has come despite the company delivering another year of record profit, record ARR, and strong cashflow. The market's reaction appears more about valuation resets and profit-taking than any deterioration in fundamentals.

The core business remains in excellent shape. TechnologyOne continues to win new customers across government, education, and corporate markets, while its SaaS+ model is transforming the speed and efficiency of ERP deployments. ARR is growing strongly, its UK expansion is accelerating, and the company has deepened its product moat through heavy investment in R&D and AI-driven enhancements.

Shaw and Partners thinks that investors should be buying the dip. This morning, the broker upgraded this Australian stock to a buy rating with a $37.30 price target. This implies potential upside of almost 30% from current levels.

Motley Fool contributor James Mickleboro has positions in CSL, Nextdc, and Technology One. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended CSL, Macquarie Group, and Technology One. The Motley Fool Australia has positions in and has recommended Macquarie Group. The Motley Fool Australia has recommended CSL and Technology One. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Broker Notes

Young man with a laptop in hand watching stocks and trends on a digital chart.
Broker Notes

Buy, hold, sell: Fortescue, Santos, CBA shares

Let's review some new expert ratings and insights on 3 ASX 200 heavyweights.

Read more »

An unhappy man in a suit sits at his desk with his arms crossed staring at his laptop screen as the PointsBet share price falls
Broker Notes

BHP, Westpac, CSL shares: Buy, sell, or hold?

One of these ASX shares is tipped to fall 13%.

Read more »

Woman tying up her shoelaces before a run.
Broker Notes

Buy, hold, sell: Coles, Wesfarmers, CSL shares

It's a new week and we've got new ratings from the experts.

Read more »

a man in a business suite throws his arms open wide above his head and raises his face with his mouth open in celebration in front of a background of an illuminated board tracking stock market movements.
Broker Notes

Top brokers name 3 ASX shares to buy next week

Brokers gave buy ratings to these ASX shares last week. Why are they bullish?

Read more »

Two male ASX investors and executives wearing dark coloured suits sit at a table holding their mobile phones discussing the highest trading ASX 200 shares today
Broker Notes

Buy, hold, sell: Resmed, Goodman Group, CBA shares

We review three fresh buy, hold, and sell calls from John Athanasiou at Red Leaf Securities.

Read more »

colleagues on a lunch break looking at iPhone
Broker Notes

Top brokers name 3 ASX shares to buy now

Here's what brokers are recommending as buys this week.

Read more »

Woman with her fingers crossed and eyes shut.
Broker Notes

7 ASX 200 shares in the buy zone as optimism returns to the market: experts

Brokers reaffirmed their buy calls on Liontown, Rio Tinto, Xero, and others this week.

Read more »

ASX shares broker ratings represented by three different coloured buttons.
Broker Notes

6 ASX shares upgraded and downgraded by the experts this week

Brokers have changed their ratings and 12-month price targets on Qantas, Codan, and others. 

Read more »